Molecular genomics of progestin actions

Hormones, Brain and Behavior Online

Volumn , Issue , 2009, Pages 1439-1466

  Tetel, M J ^a   Lange, C A ^b  

^a WELLESLEY COLLEGE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Breast cancer; Chromatin; Coregulator; Cyclin d1; Gene expression; Histone acetyltransferase activity; Hypothalamus; Mitogen activated protein kinase; Nuclear receptor coactivator; Phosphorylation; Progestin receptor; Steroid hormone; Steroid receptor coactivator 1

Indexed keywords

EID: 84884801678     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-008088783-8.00044-9     Document Type: Chapter

References (279)

1. Abdel-Hafiz H., Takimoto G.S., Tung L., Horwitz K.B. The inhibitory function in human progesterone receptor N termini binds SUMO-1 protein to regulate autoinhibition and transrepression. Journal of Biological Chemistry 2002, 277:33950-33956.
2. Agoulnik I.U., Krause W.C., Bingman W.E., Rahman H.T., Amrikachi M., Ayala G.E., Weigel N.L. Repressors of androgen and progesterone receptor action. Journal of Biological Chemistry 2003, 278:31136-31148.
3. Ali S., Metzger D., Bornert J.M., Chambon P. Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region. EMBO Journal 1993, 12:1153-1160.
4. Allan G.F., Ing N.H., Tsai S.Y., et al. Synergism between steroid response and promoter elements during cell-free transcription. Journal of Biological Chemistry 1991, 266:5905-5910.
5. Altucci L., Addeo R., Cicatiello L., et al. 17Beta-estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells. Oncogene 1996, 12:2315-2324.
6. An B.S., Selva D.M., Hammond G.L., Rivero-Muller A., Rahman N., Leung P.C. Steroid receptor coactivator-3 is required for progesterone receptor trans-activation of target genes in response to gonadotropin-releasing hormone treatment of pituitary cells. Journal of Biological Chemistry 2006, 281:20817-20824.
7. Anzick S.L., Azorsa D., Simons S.S., Meltzer P.S. Phenotypic alterations in breast cancer cells overexpressing the nuclear receptor co-activator AIB 1. BMC Cancer 2003, 3:1-11.
8. Anzick S.L., Kononen J., Walker R.L., et al. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 1997, 277:965-968.
9. Aoyagi S., Archer T.K. Dynamic histone acetylation/deacetylation with progesterone receptor-mediated transcription. Molecular Endocrinology 2007, 21:843-856.
10. Aoyagi S., Archer T.K. Dynamics of coactivator recruitment and chromatin modifications during nuclear receptor mediated transcription. Molecular and Cellular Endocrinology 2008, 280:1-5.
11. Apostolakis E.M., Ramamurphy M., Zhou D., Onate S., O'Malley B.W. Acute disruption of select steroid receptor coactivators prevents reproductive behavior in rats and unmasks genetic adaptation in knockout mice. Molecular Endocrinology 2002, 16:1511-1523.
12. Auger A.P., Perrot-Sinai T.S., Auger C.J., Ekas L.A., Tetel M.J., McCarthy M.M. Expression of the nuclear receptor coactivator, cAMP response element-binding protein, is sexually dimorphic and modulates sexual differentiation of neonatal rat brain. Endocrinology 2002, 143:3009-3016.
13. Auger A.P., Tetel M.J., McCarthy M.M. Steroid receptor coactivator-1 mediates the development of sex specific brain morphology and behavior. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:7551-7555.
14. Auger C.J., Bentley G.E., Auger A.P., Ramamurthy M., Ball G.F. Expression of cAMP response element binding protein-binding protein in the song control system and hypothalamus of adult European starlings (Sturnus vulgaris). Journal of Neuroendocrinology 2002, 14:805-813.
15. Auger C.J., Jessen H.M., Auger A.P. Microarray profiling of gene expression patterns in adult male rat brain following acute progesterone treatment. Brain Research 2006, 1067:58-66.
16. Bain D.L., Franden M.A., McManaman J.L., Takimoto G.S., Horwitz K.B. The N-terminal region of the human progesterone A-receptor. Structural analysis and the influence of the DNA binding domain. Journal of Biological Chemistry 2000, 275:7313-7320.
17. Ballare C., Uhrig M., Bechtold T., et al. Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src/Erk pathway in mammalian cells. Molecular Cellular Biology 2003, 23:1994-2008.
18. Bannister A.J., Kouzarides T. The CBP co-activator is a histone acetyltransferase. Nature 1996, 384:641-643.
19. Baum M.J., DeGreef W.J., Kloet G.A., Schretlen P.J. Evidence that a factor besides progesterone, prolactin, or plasma-estradiol-binding protein inhibits estrogen-induced sexual receptivity in pregnant rats. Journal of Comparative and Physiological Psychology 1979, 93:278-294.
20. Beato M., Sánchez-Pacheco A. Interaction of steroid hormone receptors with the transcription initiation complex. Endocrine Reviews 1996, 17:587-609.
21. Beck C.A., Weigel N.L., Edwards D.P. Effects of hormone and cellular modulators of protein phosphorylation on transcriptional activity, DNA binding, and phosphorylation of human progesterone receptors. Molecular Endocrinology 1992, 6:607-620.
22. Beck C.A., Zhang Y., Altmann M., Weigel N.L., Edwards D.P. Stoichiometry and site-specific phosphorylation of human prgoesterone receptor in native target cells and in the baculovirus expression system. Journal of Biological Chemistry 1996, 271:19546-19555.
23. Beyer C., Gonzalez-Flores O., Gonzalez-Mariscal G. Ring A reduced progestins potently stimulate estrous behavior in rats: Paradoxical effect through the progesterone receptor. Physiology and Behavior 1995, 58:985-993.
24. Blaustein J.D., Feder H.H. Cytoplasmic progestin receptors in female guinea pig brain and their relationship to refractoriness in expression of female sexual behavior. Brain Research 1979, 177:489-498.
25. Blaustein J.D., Feder H.H. Cytoplasmic progestin receptors in guinea pig brain: Characteristics and relationship to the induction of sexual behavior. Brain Research 1979, 169:481-497.
26. Blaustein J.D., Feder H.H. Progesterone at plasma levels lower than those of mid-pregnancy decreases sexual behavior in ovariectomized rats. Physiology Behavior 1979, 23:1099-1104.
27. Blaustein J.D., Mani S.K. Feminine sexual behavior from neuroendocrine and molecular neurobiological perspectives. Handbook of Neurochemistry and Molecular Neurobiology 2006, 95-150. Springer, New York. J.D. Blaustein (Ed.).
28. Blaustein J.D., Turcotte J.C. Estradiol-induced progestin receptor immunoreactivity is found only in estrogen receptor-immunoreactive cells in guinea pig brain. Neuroendocrinology 1989, 49:454-461.
29. Blaustein J.D., Wade G.N. Sequential inhibition of sexual behavior by progesterone in female rats: Comparison with a synthetic antiestrogen. Journal of Comparative Physiological Psychology 1977, 91:752-760.
30. Boonyaratanakornkit V., Melvin V., Prendergast P., et al. High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells. Molecular and Cellular Biology 1998, 18:4471-4487.
31. Boonyaratanakornkit V., Scott M.P., Ribon V., et al. Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Molecular and Cellular Biology 2001, 8:269-280.
32. Booth J.E. Sexual behaviour of neonatally castrated rats injected during infancy with oestrogen and dihydrotestosterone. Journal of Endocrinology 1977, 72:135-141.
33. Bousios S., Karandrea D., Kittas C., Kitraki E. Effects of gender and stress on the regulation of steroid receptor coactivator-1 expression in the rat brain and pituitary. Journal of Steroid Biochemistry and Molecular Biology 2001, 78:401-407.
34. Brady M.E., Ozanne D.M., Gaughan L., Waite I., Cook S., Neal D.E., Robson C.N. Tip60 is a nuclear hormone receptor coactivator. Journal of Biological Chemistry 1999, 274:17599-17604.
35. Brass A.L., Barnard J., Patai B.L., Salvi D., Rukstalis D.B. Androgen up-regulates epidermal growth factor receptor expression and binding affinity in PC3 cell lines expressing the human androgen receptor. Cancer Research 1995, 55:3197-3203.
36. Camacho-Arroyo I., Neri-Gomez T., Gonzalez-Arenas A., Guerra-Araiza C. Changes in the content of steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid hormone receptors in the rat brain during the estrous cycle. Journal of Steroid Biochemistry and Molecular Biology 2005, 94:267-272.
37. Carroll J.S., Brown M. Estrogen receptor target gene: An evolving concept. Molecular Endocrinology 2006, 20:1707-1714.
38. Carroll J.S., Liu X.S., Brodsky A.S., et al. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 2005, 122:33-43.
39. Cavarretta I.T.R., Mukopadhyay R., Lonard D.M., Cowsert L.M., Bennet C.F., O'Malley B., Smith C.L. Reduction of coactivator expression by antisense oligodeoxynucleotides inhibits ERa transcriptional activity and MCF-7 proliferation. Molecular Endocrinology 2002, 16(2):253-269.
40. Chalbos D., Chambon M., Ailhaud G., Rochefort H. Fatty acid synthetase and its mRNA are induced by progestins in breast cancer cells. Journal of Bioloigcal Chemistry 1987, 262:9923-9926.
41. Charlier T.D., Ball G.F., Balthazart J. Inhibition of steroid receptor coactivator-1 blocks estrogen and androgen action on male sex behavior and associated brain plasticity. Journal of Neuroscience 2005, 25:906-913.
42. Charlier T.D., Ball G.F., Balthazart J. Plasticity in the expression of the steroid receptor coactivator-1 in the Japanese quail brain: Effect of sex, testosterone, stress and time of the day. Neuroscience 2006, 172:333-343.
43. Charlier T.D., Harada N., Ball G.F., Balthazart J. Targeting steroid receptor coactivator-1 expression with locked nucleic acids antisense reveals different thresholds for the hormonal regulation of male sexual behavior in relation to aromatase activity and protein expression. Behavioral Brain Research 2006, 172:333-343.
44. Charlier T.D., Lakaye B., Ball G.F., Balthazart J. Steroid receptor coactivator SRC-1 exhibits high expression in steroid-sensitive brain areas regulating reproductive behaviors in the quail brain. Neuroendocrinology 2002, 76:297-315.
45. Chen D., Huang S.M., Stallcup M.R. Synergistic, p160 coactivator-dependent enhancement of estrogen receptor function by CARM1 and p300. Journal of Biological Chemistry 2000, 275:40810-40816.
46. Chen D., Ma H., Hong H., et al. Regulation of transcription by a protein methyltransferase. Science 1999, 284:2174-2177.
47. Chen H., Lin R.J., Schiltz R.L., et al. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 1997, 90:569-580.
48. Chen J.D., Evans R.M. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 1995, 377:454-457.
49. Cheng M., Sexl V., Sherr C.J., Roussel M.F. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). Proceedings of the National Academy of Science of the United States of America 1998, 95:1091-1096.
50. Chrivia J.C., Kwok R.P., Lamb N., Hagiwara M., Montminy M.R., Goodman R.H. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 1993, 365:855-859.
51. Chu H.P., Morales J.C., Etgen A.M. Cyclic GMP may potentiate lordosis behaviour by progesterone receptor activation. Journal of Neuroendocrinology 1999, 11:107-113.
52. Church D.R., Lee E., Thompson T.A., Basu H.S., Ripple M.O., Ariazi E.A., Wilding G. Induction of AP-1 activity by androgen activation of the androgen receptor in LNCaP human prostate carcinoma cells. Prostate 2005, 63:155-168.
53. Clemm D.L., Sherman L., Boonyaratanakornkit V., Schrader W.T., Weigel N.L., Edwards D.P. Differential hormone-dependent phosphorylation of progesterone receptor A and B forms revealed by a phosphoserine site-specific monoclonal antibody. Molecular Endocrinology 2000, 14:52-65.
54. Condon J.C., Hardy D.B., Kovaric K., Mendelson C.R. Up-regulation of the progesterone receptor (PR)-C isoform in laboring myometrium by activation of nuclear factor-kappaB may contribute to the onset of labor through inhibition of PR function. Molecular Endocrinology 2006, 20:764-775.
55. Conneely O.M., Maxwell B.L., Toft D.O., Schrader W.T., O'Malley B.W. The A and B forms of the chicken progesterone receptor arise by alternate initiation of translation of a unique mRNA. Biochemical and Biophysical Research Communications 1987, 2:493-501.
56. Cui X., Lazard Z., Zhang P., Hopp T.A., Lee A.V. Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2. Oncogene 2003, 22:6937-6941.
57. Daniel A.R., Faivre E.J., Lange C.A. Phosphorylation-dependent antagonism of sumoylation derepresses progesterone receptor action in breast cancer cells. Molecular Endocrinology 2007, 21:2890-2906.
58. Daniel A.R., Qiu M., Faivre E.J., Ostrander J.H., Skildum A., Lange C.A. Linkage of progestin and epidermal growth factor signaling: Phosphorylation of progesterone receptors mediates transcriptional hypersensitivity and increased ligand-independent breast cancer cell growth. Steroids 2007, 72:188-201.
59. De Nicola A.F., Gonzalez S.L., Labombarda F., Deniselle M.C., Garay L., Guennoun R., Schumacher M. Progesterone treatment of spinal cord injury: Effects on receptors, neurotrophins, and myelination. Journal of Molecular Neuroscience 2006, 28:3-15.
60. Demarzo A., Beck C.A., Oñate S.A., Edwards D.P. Dimerization of mammalian progesterone receptors occurs in the absence of DNA and is related to the release of the 90-kDa heat shock protein. Proceedings of the National Academy of Sciences of the United States of America 1991, 88:72-76.
61. Dempsey E.W., Hertz R., Young W.C. The experimental induction of oestrus (sexual receptivity) in the normal and ovariectomized guinea pig. American Journal of Physiology 1936, 116:201-209.
62. Deroo B.J., Archer T.K. Glucocorticoid receptor-mediated chromatin remodeling in vivo. Oncogene 2001, 20:3039-3046.
63. Duffy D.M., Wells T.R., Haluska G.J., Stouffer R.L. The ratio of progesterone receptor isoforms changes in the monkey corpus luteum during the luteal phase of the menstrual cycle. Biology of Reproduction 1997, 57:693-699.
64. Duncan K.A., Carruth L.L. The sexually dimorphic expression of L7/SPA, an estrogen receptor coactivator, in zebra finch telencephalon. Developmental Neurobiology 2007, 67:1852-1866.
65. Dutertre M., Smith C.L. Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-à: Regulation by phosphorylation sites in the A/B region depends on other receptor domains. Molecular Endocrinology 2003, 17:1296-1314.
66. Edwards D.A., Pfeifle J.K. Hormonal control of receptivity, proceptivity and sexual motivation. Physiological Behavior 1983, 30:437-443.
67. Edwards D.P. The role of coactivators and corepressors in the biology and mechanism of action of steroid hormone receptors. Journal of Mammary Gland Biology and Neoplasia 2000, 5:307-324.
68. Edwards D.P., Wardell S.E., Boonyaratanakornkit V. Progesterone receptor interacting coregulatory proteins and cross talk with cell signaling pathways. Journal of Steroid Biochemistry and Molecular Biology 2002, 83:173-186.
69. Erskine M.S. Solicitation behavior in the estrous female rat: A review. Hormones and Behavior 1989, 23:473-502.
70. Etgen A.M., Gonzalez-Flores O., Todd B.J. The role of insulin-like growth factor-I and growth factor-associated signal transduction pathways in estradiol and progesterone facilitation of female reproductive behaviors. Frontiers in Neuroendocrinology 2006, 27:363-375.
71. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science 1988, 240:889-895.
72. Fadem B.H., Barfield R.J., Whalen R.E. Dose-response and time-response relationships between progesterone and the display of patterns of receptive and proceptive behavior in the female rat. Hormones and Behavior 1979, 13:40-48.
73. Faivre E.J., Daniel A.R., Hillard C.J., Lange C.A. Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors. Molecular Endocrinology 2008, 22:823-837.
74. Faivre E.J., Lange C.A. Progesterone receptors upregulate Wnt-1 to induce epidermal growth factor receptor transactivation and c-Src-dependent sustained activation of Erk1/2 mitogen-activated protein kinase in breast cancer cells. Molecular and Cellular Biology 2007, 27:466-480.
75. Fantl V., Stamp G., Andrews A., Rosewell I., Dickson C. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes and Development 1995, 9:2364-2372.
76. Fernandez-Valdivia R., Mukherjee A., Amato P., Allred D.C., Nguyen J., Demayo F.J., Lydon J.P. Progesterone-action in the murine uterus and mammary gland requires steroid receptor coactivator 2: Relevance to the human. Frontiers in Bioscience 2007, 12:3640-3647.
77. Font De Mora J., Brown M. AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor. Molecular and Cellular Biology 2000, 20:5041-5047.
78. Galeeva A.Y., Pivina S.G., Tuohimaa P., Ordyan N.E. Involvement of nuclear progesterone receptors in the formation of anxiety in female mice. Neuroscience and Behavioral Physiology 2007, 37:843-848.
79. Gehin M., Mark M., Dennefeld C., Dierich A., Gronemeyer H., Chambon P. The function of TIF2/GRIP1 in mouse reproduction is distinct from those of SRC-1 and p/CIP. Molecular and Cellular Biology 2002, 22:5923-5937.
80. Ghatge R.P., Jacobsen B.M., Schittone S.A., Horwitz K.B. The progestational and androgenic properties of medroxyprogesterone acetate: Gene regulatory overlap with dihydrotestosterone in breast cancer cells. Breast Cancer Research 2005, 7:R1036-R1050.
81. Giangrande P.H., Kimbrel A., Edwards D.P., McDonnell D.P. The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding. Molecular and Cellular Biology 2000, 20:3102-3115.
82. Giangrande P.H., Pollio G., McDonnell D.P. Mapping and characterization of the functional domains responsible for the differential activity of the A and B isoforms of the human progesterone receptor. Journal of Biological Chemistry 1997, 272:32889-32900.
83. Gillett C., Fantl V., Smith R., et al. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Research 1994, 54:1812-1817.
84. Gonzalez-Flores O., Guerra-Araiza C., Cerbon M., Camacho-Arroyo I., Etgen A.M. The 26S proteasome participates in the sequential inhibition of estrous behavior induced by progesterone in rats. Endocrinology 2004, 145:2328-2336.
85. Gonzalez-Flores O., Shu J., Camacho-Arroyo I., Etgen A.M. Regulation of lordosis by cyclic 3′,5′-guanosine monophosphate, progesterone, and its 5 alpha-reduced metabolites involves mitogen-activated protein kinase. Endocrinology 2004, 145:5560-5567.
86. Gorzalka B.B., Whalen R.E. The effects of progestins, mineralocorticoids, glucocorticoids, and steroid solubility on the induction of sexual receptivity in rats. Hormones and Behavior 1977, 8:94-99.
87. Graham J.D., Yager M.L., Hill H.D., Byth K., O'Neill G.M., Clarke C.L. Altered progesterone receptor isoform expression remodels progestin responsiveness of breast cancer cells. Molecular Endocrinology 2005, 19:2713-2735.
88. Graham J.D., Yeates C., Balleine R.L., Harvey S.S., Milliken J.S., Bilous A.M., Clarke C.L. Characterization of progesterone receptor A and B expression in human breast cancer. Cancer Research 1995, 55:5063-5068.
89. Gregory C.W., Johnson R.T., Presnell S.C., Mohler J.L., French F.S. Androgen receptor regulation of G1 cyclin and cyclin-dependent kinase function in the CWR22 human prostate cancer xenograft. Journal of Andrology 2001, 22:537-548.
90. Grenier J., Trousson A., Chauchereau A., Cartaud J., Schumacher M., Massaad C. Differential recruitment of p160 coactivators by glucocorticoid receptor between Schwann cells and astrocytes. Molecular Endocrinology 2005, 20:254-267.
91. Gronemeyer H., Turcotte B., Quirin-Stricker C., et al. The chicken progesterone receptor: Sequence, expression and functional analysis. EMBO Journal 1987, 6:3985-3994.
92. Groshong S.D., Owen G.I., Grimison B., et al. Biphasic regulation of breast cancer cell growth by progesterone: Role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1). Molecular Endocrinology 1997, 11:1593-1607.
93. Grunstein M. Histone acetylation in chromatin structure and transcription. Nature 1997, 389:349-352.
94. Haas D., White S.N., Lutz L.B., Rasar M., Hammes S.R. The modulator of nongenomic actions of the estrogen receptor (MNAR) regulates transcription-independent androgen receptor-mediated signaling: Evidence that MNAR participates in G protein-regulated meiosis in Xenopus laevis oocytes. Molecular Endocrinology 2005, 19:2035-2046.
95. Halbreich U., Endicott J., Goldstein S., Nee J. Premenstrual changes and changes in gonadal hormones. Acta Psychiatrica Scandinavica 1986, 74:576-586.
96. Han S.J., Demayo F.J., Xu J., Tsai S.Y., Tsai M.J., O'Malley B.W. Steroid receptor coactivator (SRC)-1 and SRC-3 differentially modulate tissue-specific activation functions of the progesterone receptor. Molecular Endocrinology 2006, 20:45-55.
97. Hardy D.F., Debold J.F. The relationship between levels of exogenous hormones and the display of lordosis by the female rat. Hormones and Behavior 1971, 2:287-297.
98. Hong H., Kohli K., Garabedian M.J., Stallcup M.R. GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors. Molecular and Cellular Biology 1997, 17:2735-2744.
99. Horlein A.J., Naar A.M., Heinzel T., et al. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 1995, 377:397-404.
100. Horwitz K.B., Sheridan P.L., Wei L.L., Krett N.L. Human progesterone receptors: Synthesis, structure, and phosphorylation. Progress in Clinical and Biological Research 1990, 322:41-52.
101. Hovland A.R., Powell R.L., Takimoto G.S., Tung L., Horwitz K.B. An N-terminal inhibitory function, IF, suppresses transcription by the A-isoform but not the B-isoform of human progesterone recpetors. Journal of Biological Chemistry 1998, 273:5455-5460.
102. Iannacone E.A., Yan A.W., Gauger K.J., Dowling A.L.S., Zoeller R.T. Thyroid hormone exerts site-specific effects on SRC-1 and NCoR expression selectively in the neonatal rat brain. Molecular and Cellular Endocrinology 2002, 186:49-59.
103. Iizuka M., Smith M.M. Functional consequences of histone modifications. Current Opinion in Genetics and Devlopment 2003, 13:154-160.
104. Ito M., Yuan C.X., Malik S., et al. Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators. Molecular Cell 1999, 3:361-370.
105. Jackson T.A., Richer J.K., Bain D.L., Takimoto G.S., Tung L., Horwitz K.B. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT. Molecular Endocrinology 1997, 11:693-705.
106. Jacobsen B.M., Richer J.K., Sartorius C.A., Horwitz K.B. Expression profiling of human breast cancers and gene regulation by progesterone receptors. Journal of Mammary Gland Biology and Neoplasia 2003, 8:257-268.
107. Jacobsen B.M., Richer J.K., Schittone S.A., Horwitz K.B. New human breast cancer cells to study progesterone receptor isoform ratio effects and ligand-independent gene regulation. Journal of Biological Chemistry 2002, 277:27793-27800.
108. Jacobsen B.M., Schittone S.A., Richer J.K., Horwitz K.B. Progesterone-independent effects of human progesterone receptors (PRs) in estrogen receptor-positive breast cancer: PR isoform-specific gene regulation and tumor biology. Molecular Endocrinology 2005, 19:574-587.
109. Jasnow A.M., Mong J.A., Romeo R.D., PfaffD.W. Estrogenic regulation of gene and protein expression within the amygdala of female mice. Endocrine 2008, 32:271-279.
110. Jeong J.W., Lee K.Y., Han S.J., Aronow B.J., Lydon J.P., O'Malley B.W., Demayo F.J. The p160 steroid receptor coactivator 2, SRC-2, regulates murine endometrial function and regulates progesterone-independent and-dependent gene expression. Endocrinology 2007, 148:4238-4250.
111. Kaltz-Wittmer C., Klenk U., Glaessgen A., Aust D.E., Diebold J., Lohrs U., Baretton G.B. FISH analysis of gene aberrations (MYC, CCND1, ERBB2, RB, and AR) in advanced prostatic carcinomas before and after androgen deprivation therapy. Laboratory Investigation 2000, 80:1455-1464.
112. Kamei Y., Xu L., Heinzel T., et al. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 1996, 85:403-414.
113. Karteris E., Zervou S., Pang Y., Dong J., Hillhouse E.W., Randeva H.S., Thomas P. Progesterone signaling in human myometrium through two novel membrane G protein-coupled receptors: Potential role in functional progesterone withdrawal at term. Molecular Endocrinology 2006, 20:1519-1534.
114. Kastner P., Krust A., Turcotte B., Stropp U., Tora L., Gronemeyer H., Chambon P. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO Journal 1990, 9:1603-1614.
115. Kawata M., McCabe J.T., Chung S.K., et al. The effect of progesterone on oxytocin messenger RNA in hypothalamic neurons of estrogen-treated female rats studied with quantitative in situ hybridization histochemistry. Biomedical Research 1991, 12:405-415.
116. Kininis M., Chen B.S., Diehl A.G., et al. Genomic analyses of transcription factor binding, histone acetylation, and gene expression reveal mechanistically distinct classes of estrogen-regulated promoters. Molecular and Cellular Biology 2007, 27:5090-5104.
117. Klein-Hitpass L., Tsai S.Y., Weigel N.L., et al. The progesterone receptor stimulates cell-free transcription by enhancing the formation of a stable preinitiation complex. Cell 1990, 60:247-257.
118. Knotts T.A., Orkiszewski R.S., Cook R.G., Edwards D.P., Weigel N.L. Identification of a phosphorylation site in the hinge region of the human progesterone receptor and additional amino-terminal phosphorylation sites. Journal of Biological Chemistry 2001, 276:8475-8483.
119. Knudsen K.E., Arden K.C., Cavenee W.K. Multiple G1 regulatory elements control the androgen-dependent proliferation of prostatic carcinoma cells. Journal of Biological Chemistry 1998, 273:20213-20222.
120. Kobayashi Y., Kitamoto T., Masuhiro Y., et al. p300 Mediates functional synergism between AF-1 and AF-2 of estrogen receptor alpha and beta by interacting directly with the N-terminal A/B domains. Journal of Biological Chemistry 2000, 275:15645-15651.
121. Krebs C.J., Jarvis E.D., PfaffD.W. The 70-kDa heat shock cognate protein (Hsc73) gene is enhanced by ovarian hormones in the ventromedial hypothalamus. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:1686-1691.
122. Krebs C.J., PfaffD.W. Expression of the SCAMP-4 gene, a new member of the secretory carrier membrane protein family, is repressed by progesterone in brain regions associated with female sexual behavior. Brain Research -Molecular Brain Research 2001, 88:144-154.
123. Krusekopf S., Chauchereau A., Milgrom E., Henderson D., Cato A.C. Co-operation of progestational steroids with epidermal growth factor in activation of gene expression in mammary tumor cells. Journal of Steroid Biochemistry and Molecular Biology 1991, 40:239-245.
124. Kurdistani S.K., Grunstein M. Histone acetylation and deacetylation in yeast. Nature Reviews Molecular Cell Biology 2003, 4:276-284.
125. Kwok R.P.S., Lundblad J.R., Chrivia J.C., et al. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 1994, 370:223-229.
126. Labriola L., Salatino M., Proietti C.J., et al. Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells. Molecular Cellular Biology 2003, 23:1095-1111.
127. Lange C.A. Making sense of cross-talk between steroid hormone receptors and intracellular signaling pathways: Who will have the last word?. Molecular Endocrinology 2004, 18:269-278.
128. Lange C.A., Gioeli D., Hammes S.R., Marker P.C. Integration of rapid signaling events with steroid hormone receptor action in breast and prostate cancer. Annual Review of Physiology 2007, 69:171-199.
129. Lange C.A., Richer J.K., Shen T., Horwitz K.B. Convergence of progesterone and epidermal growth factor signaling in breast cancer. Potentiation of mitogen-activated protein kinase pathways. Journal of Biological Chemistry 1998, 273:31308-31316.
130. Lange C.A., Shen T., Horwitz K.B. Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:1032-1037.
131. Lanz R.B., Chua S.S., Barron N., Soder B.M., Demayo F., O'Malley B.W. Steroid receptor RNA activator stimulates proliferation as well as apoptosis in vivo. Molecular and Cellular Biology 2003, 23:7163-7176.
132. Lanz R.B., McKenna N.J., Oñate S.A., et al. A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell 1999, 97:17-27.
133. Lauber A.H., Romano G.J., PfaffD.W. Sex difference in estradiol regulation of progestin receptor messenger RNA in rat mediobasal hypothalamus as demonstrated by in situ hybridization. Neuroendocrinology 1991, 53:608. 613.
134. Lees J.A., Fawell S.E., Parker M.G. Identification of two transactivation domains in the mouse oestrogen receptor. Nucleic Acid Research 1989, 17:5477-5487.
135. Leo J.C., Wang S.M., Guo C.H., et al. Gene regulation profile reveals consistent anticancer properties of progesterone in hormone-independent breast cancer cells transfected with progesterone receptor. International Journal of Cancer 2005, 117:561-568.
136. Lessey B.A., Alexander P.S., Horwitz K.B. The subunit structure of human breast cancer progesterone receptors: Characterization by chromatography and photoaffinity labeling. Endocrinology 1983, 112:1267-1274.
137. Li H., Gomes P.J., Chen J.D. RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:8479-8484.
138. Li X., Wong J., Tsai M.J., O'Malley B. Progesterone and glucocorticoid receptors recruit distinct coactivator complexes and promote distinct patterns of local chromatin modification. Molecular and Cellular Biology 2003, 23:3763-3773.
139. Liu Z., Wong J., Tsai S.Y., Tsai M.J., O'Malley B.W. Sequential recruitment of steroid receptor coactivator-1 (SRC-1) and p300 enhances progesterone receptor-dependent initiation and reinitiation of transcription from chromatin. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:12426-12431.
140. Lonard D.M., Lanz R.B., O'Malley B.W. Nuclear receptor coregulators and human disease. Endocrine Reviews 2007, 28:575-587.
141. Lonard D.M., O'Malley B.W. The expanding cosmos of nuclear receptor coactivators. Cell 2006, 125:411-414.
142. Lydon J.P., Demayo F.J., Conneely O.M., O'Malley B.W. Reproductive phenotypes of the progesterone receptor null mutant mouse. Journal of Steroid Biochemistry and Molecular Biology 1996, 56:67-77.
143. Maclusky N.J., McEwen B.S. Oestrogen modulates progestin receptor concentrations in some rat brain regions but not in others. Nature 1978, 274:276-278.
144. Maerkel K., Durrer S., Henseler M., Schlumpf M., Lichtensteiger W. Sexually dimorphic gene regulation in brain as a target for endocrine disrupters: Developmental exposure of rats to 4-methylbenzylidene camphor. Toxicology and Applied Pharmacology 2007, 218:152-165.
145. Malyala A., Pattee P., Nagalla S.R., Kelly M.J., Ronnekleiv O.K. Suppression subtractive hybridization and microarray identification of estrogen-regulated hypothalamic genes. Neurochemical Research 2004, 29:1189-1200.
146. Mangelsdorf D.J., Thummel C., Beato M., et al. The nuclear receptor superfamily: The second decade. Cell 1995, 83:835-839.
147. Mani S.K., Reyna A.M., Chen J.Z., et al. Differential response of progesterone receptor isoforms in hormone-dependent and -independent facilitation of female sexual receptivity. Molecular Endocrinology 2006, 20:1322-1332.
148. Marino M., Acconcia F., Bresciani F., Weisz A., Trentalance A. Distinct nongenomic signal transduction pathways controlled by 17beta-estradiol regulate DNA synthesis and cyclin D(1) gene transcription in HepG2 cells. Molecular Biology of the Cell 2002, 13:3720-3729.
149. Martinez De Arrieta C., Koibuchi N., Chin W.W. Coactivator and corepressor gene expression in rat cerebellum during postnatal development and the effect of altered thyroid status. Endocrinology 2000, 141:1693-1698.
150. McCarthy M.M., Schlenker E.H., PfaffD.W. Enduring consequences of neonatal treatment with antisense oligodeoxynucleotides to estrogen receptor messenger ribonucleic acid on sexual differentiation of rat brain. Endocrinology 1993, 133:433-439.
151. McDonnell D.P., Goldman M.E. RU486 exerts antiestrogenic activities through a novel progesterone receptor A form-mediated mechanism. Journal of Biological Chemistry 1994, 269:11945-11949.
152. McEwen B. Estrogen actions throughout the brain. Recent Progress in Hormone Research 2002, 57:357-384.
153. McGinnis M.Y., Lumia A.R., Tetel M.J., Molenda-Figuiera H.A., Possidente B. Effects of androgenic steroids on the development and expression of running wheel activity and circadian rhythms in male rats. Physiology and Behavior 2007, 92:1010-1018.
154. McGowan E.M., Clarke C.L. Effect of overexpression of progesterone receptor A on endogenous progestin-sensitive endpoints in breast cancer cells. Molecular Endocrinology 1999, 13:1657-1671.
155. McInerney E.M., Tsai M.J., O'Malley B.W., Katzenellenbogen B.S. Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:10069-10073.
156. McKenna N.J., Lanz R.B., O'Malley B.W. Nuclear receptor coregulators: Cellular and molecular biology. EndocrineReviews 1999, 20:321-344.
157. McKenna N.J., Nawaz Z., Tsai S.Y., Tsai M.J., O'Malley B.W. Distinct steady-state nuclear receptor coregulator complexes exist in vivo. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:11697-11702.
158. Meijer O.C., Steenbergen P.J., DeKloet E.R. Differential expression and regional distribution of steroid receptor coactivators SRC-1 and SRC-2 in brain and pituitary. Endocrinology 2000, 141:2192-2199.
159. Meijer O.C., VanDer L.S., Lachize S., Steenbergen P.J., DeKloet E.R. Steroid receptor coregulator diversity: What can it mean for the stressed brain?. Neuroscience 2006, 138:891-899.
160. Meisel R.L., Fraile I.G., PfaffD.W. Hypothalamic sites of progestin action on aggression and sexual behavior in female syrian hamsters. Physiology and Behavior 1990, 47:219-223.
161. Meyer M.E., Pornon A., Ji J.W., Bocquel M.T., Chambon P., Gronemeyer H. Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor. EMBO Journal 1990, 9:3923-3932.
162. Meyer M.E., Quirin-Stricker C., Lerouge T., Bocquel M.T., Gronemeyer H. A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms. Journal of Biological Chemistry 1992, 267:10882-10887.
163. Migliaccio A., DiDomenico M., Castoria G., De Falco A., Bontempo P., Nola E., Auricchio F. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO Journal 1996, 15:1292-1300.
164. Migliaccio A., Di Domenico M., Green S., et al. Phosphorylation on tyrosine of in vitro synthesized human estrogen receptor activates its hormone binding. Molecular Endocrinology 1989, 3:1061-1069.
165. Migliaccio A., Piccolo D., Castoria G., et al. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO Journal 1998, 17:2008-2018.
166. Misiti S., Schomburg L., Yen P.M., Chin W.W. Expression and hormonal regulation of coactivator and corepressor genes. Endocrinology 1998, 139:2493-2500.
167. Mitev Y.A., Wolf S.S., Almeida O.F., Patchev V.K. Developmental expression profiles and distinct regional estrogen responsiveness suggest a novel role for the steroid receptor coactivator SRC-l as a discriminative amplifier of estrogen signaling in the rat brain. FASEB Journal 2003, 17:518-519.
168. Moguilewsky M., Raynaud J.P. The relevance of hypothalamic and hyphophyseal progestin receptor regulation in the induction and inhibition of sexual behavior in the female rat. Endocrinology 1979, 105:516-522.
169. Molenda-Figueira H.A., Muphy S.D., Shea K.L., et al. Steroid receptor coactivator-1 from brain physically interacts differentially with steroid receptor. Endocrinology 2008, 149:5272-5279.
170. Molenda-Figueira H.A., Williams C.A., Griffin A.L., Rutledge E.M., Blaustein J.D., Tetel M.J. Nuclear receptor coactivators function in estrogen receptor- and progestin receptor-dependent aspects of sexual behavior in female rats. Hormones and Behavior 2006, 50:383-392.
171. Molenda H.A., Griffin A.L., Auger A.P., McCarthy M.M., Tetel M.J. Nuclear receptor coactivators modulate hormone-dependent gene expression in brain and female reproductive behavior in rats. Endocrinology 2002, 143:436-444.
172. Molenda H.A., Kilts C., Allen R.L., Tetel M.J. Nuclear receptor coactivator function in reproductive physiology and behavior. Biology of Reproduction 2003, 69:1449-1457.
173. Moore M.R., Zhou J.L., Blankenship K.A., Strobl J.S., Edwards D.P., Gentry R.N. A sequence in the 5′ flanking region confers progestin responsiveness on the human c-myc gene. Journal of Steroid Biochemistry and Molecular Biology 1997, 62:243-252.
174. Morin L.P. Progesterone: Inhibition of rodent sexual behavior. Physiology and Behavior 1977, 18:701-715.
175. Mukherjee A., Amato P., Allred D.C., Demayo F.J., Lydon J.P. Steroid receptor coactivator 2 is required for female fertility and mammary morphogenesis: Insights from the mouse, relevance to the human. Nuclear Receptor Signaling 2007, 5:1-7.
176. Mukherjee A., Soyal S.M., Fernandez-Valdivia R., et al. Steroid receptor coactivator 2 is critical for progesterone-dependent uterine function and mammary morphogenesis in the mouse. Molecular and Cellular Biology 2006, 26:6571-6583.
177. Mulac-Jericevic B., Lydon J.P., Demayo F.J., Conneely O.M. Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:9744-9749.
178. Mulac-Jericevic B., Mullinax R.A., Demayo F.J., Lydon J.P., Conneely O.M. Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science 2000, 289:1751-1754.
179. Mulholland N.M., Soeth E., Smith C.L. Inhibition of MMTV transcription by HDAC inhibitors occurs independent of changes in chromatin remodeling and increased histone acetylation. Oncogene 2003, 22:4807-4818.
180. Murphy L.O., Blenis J. MAPK signal specificity: The right place at the right time. Trends in Biochemical Sciences 2006, 31:268-275.
181. Narayanan R., Adigun A.A., Edwards D.P., Weigel N.L. Cyclin-dependent kinase activity is required for progesterone receptor function: Novel role for cyclin A/Cdk2 as a progesterone receptor coactivator. Molecular and Cellular Biology 2005, 25:264-277.
182. Narayanan R., Edwards D.P., Weigel N.L. Human progesterone receptor displays cell cycle-dependent changes in transcriptional activity. Molecular and Cellular Biology 2005, 25:2885-2898.
183. Nardulli A.M., Katzenellenbogen B.S. Progesterone receptor regulation in T47D human breast cancer cells: Analysis by density labeling of progesterone receptor synthesis and degradation and their modulation by progestin. Endocrinology 1988, 122:1532-1540.
184. Numan M., Roach J.K., del Carro M.C., Guillamon A., Segovia S., Sheehan T.P., Numan M.J. Expression of intracellular progesterone receptors in rat brain during different reproductive states, and involvement in maternal behavior. Brain Research 1999, 830:358-371.
185. O'Malley B.W. Molecular biology. Little molecules with big goals. Science 2006, 313:1749-1750.
186. O'Malley B.W. Coregulators: From whence came these 'master genes'. Molecular Endocrinology 2007, 21:1009-1013.
187. Ogawa H., Nishi M., Kawata M. Localization of nuclear coactivators p300 and steroid receptor coactivator 1 in the rat hippocampus. Brain Research 2001, 890:197-202.
188. Ogawa S., Olazabal U.E., Parhar I.S., PfaffD.W. Effects of intrahypothalamic administration of antisense DNA for progesterone receptor mRNA on reproductive behavior and progesterone receptor immunoreactivity in female rat. Journal of Neuroscience 1994, 14:1766-1774.
189. Ogryzko V.V., Schiltz R.L., Russanova V., Howard B.H., Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 1996, 87:953-959.
190. Oike Y., Hata A., Mamiya T., Kaname T., et al. Truncated CBP protein leads to classical Rubinstein-Taybi syndrome phenotypes in mice: Implications for a dominant-negative mechanism. Human Molecular Genetics 1999, 8:387-396.
191. Oñate S.A., Boonyaratanakornkit V., Spencer T.E., Tsai S.Y., Tsai M.J., Edwards D.P., O'Malley B.W. The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptors. Journal of Biological Chemistry 1998, 273:12101-12108.
192. Oñate S.A., Tsai S.Y., Tsai M.J., O'Malley B.W. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 1995, 270:1354-1357.
193. Owen G.I., Richer J.K., Tung L., Takimoto G., Horwitz K.B. Progesterone regulates transcription of the p21(WAF1) cyclin-dependent kinase inhibitor gene through Sp1 and CBP/p300. Journal of Biological Chemistry 1998, 273:10696-10701.
194. Parsons B., McGinnis M.Y., McEwen B.S. Sequential inhibition of progesterone: Effects on sexual receptivity and associated changes in brain cytosol progestin binding in the female rat. Brain Research 1981, 221:149-160.
195. Petrij F., Giles R.H., Dauwerse H.G., et al. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 1995, 376:348-351.
196. PfaffD. Hormone-driven mechanisms in the central nervous system facilitate the analysis of mammalian behaviours. Journal of Endocrinology 2005, 184:447-453.
197. PfaffD.W. Estrogens and Brain Function 1980, Springer, New York.
198. Pierson-Mullany L.K., Lange C.A. Phosphorylation of progesterone receptor serine 400 mediates ligand-independent transcriptional activity in response to activation of cyclin-dependent protein kinase 2. Molecular and Cellular Biology 2004, 24:10542-10557.
199. Pleim E.T., Brown T.J., Maclusky N.J., Etgen A.M., Barfield R.J. Dilute estradiol implants and progestin receptor induction in the ventromedial nucleus of the hypothalamus: Correlation with receptive behavior in female rats. Endocrinology 1989, 124:1807-1812.
200. Poletti A., Coscarella A., Negri-Cesi P., Colciago A., Celotti F., Martini L. 5 Alpha-reductase isozymes in the central nervous system. Steroids 1998, 63:246-251.
201. Pratt W.B., Galigniana M.D., Morishima Y., Murphy P.J. Role of molecular chaperones in steroid receptor action. Essays of Biochemistry 2004, 40:41-58.
202. Proietti C., Salatino M., Rosemblit C., et al. Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells. Molecular and Cellular Biology 2005, 25:4826-4840.
203. Qiu M., Lange C.A. MAP kinases couple multiple functions of human progesterone receptors: Degradation, transcriptional synergy, and nuclear association. Journal of Steroid Biochemistry and Molecular Biology 2003, 85:147-157.
204. Qiu M., Olsen A., Faivre E., Horwitz K.B., Lange C.A. Mitogen-activated protein kinase regulates nuclear association of human progesterone receptors. Molecular Endocrinology 2003, 17:628-642.
205. Ramos H.E., Weiss R.E. Regulation of nuclear coactivator and corepressor expression in mouse cerebellum by thyroid hormone. Thyroid 2006, 16:211-216.
206. Reddy A.P., Bethea C.L. Preliminary array analysis reveals novel genes regulated by ovarian steroids in the monkey raphe region. Psychopharmacology (Berl) 2005, 180:125-140.
207. Richer J.K., Jacobsen B.M., Manning N.G., Abel M.G., Wolf D.M., Horwitz K.B. Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. Journal of Biological Chemistry 2002, 277:5209-5218.
208. Richer J.K., Lange C.A., Manning N.G., Owen G., Powell R., Horwitz K.B. Convergence of progesterone with growth factor and cytokine signaling in breast cancer. Progesterone receptors regulate signal transducers and activators of transcription expression and activity. Journal of Biological Chemistry 1998, 273:31317-31326.
209. Robyr D., Wolffe A.P., Wahli W. Nuclear hormone receptor coregulators in action: Diversity for shared tasks. Molecular Endocrinology 2000, 14:329-347.
210. Rosenfeld M.G., Lunyak V.V., Glass C.K. Sensors and signals: A coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes and Development 2006, 20:1405-1428.
211. Rowan B.G., O'Malley B.W. Progesterone receptor coactivators. Steroids 2000, 65:545-549.
212. Sandstrom N.J., Williams C.L. Memory retention is modulated by acute estradiol and progesterone replacement. Behavioral Neuroscience 2001, 115:384-393.
213. Sartorius C.A., Melville M.Y., Hovland A.R., Tung L., Takimoto G.S., Horwitz K.B. A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform. Molecular Endocrinology 1994, 8:1347-1360.
214. Schott D.R., Shyamala G., Schneider W., Parry G. Molecular cloning, sequence analyses, and expression of complementary DNA encoding murine progesterone receptor. Biochemistry 1991, 30:7014-7020.
215. Schwabe J.W.R., Neuhaus D., Rhodes D. Solution structure of the DNA-binding domain of the oestrogen receptor. Nature 1990, 348:458-461.
216. Scott R.E.M., Wu-Peng X.S., PfaffD.W. Regulation and expression of progesterone receptor mRNA isoforms A and B in the male and female rat hypothalamus and pituitary following oesterogen treatment. Journal of Neuroendocrinology 2002, 14:175-183.
217. Shearman L.P., Zylka M.J., Reppert S.M., Weaver D.R. Expression of basic helix-loop-helix/PAS genes in the mouse suprachiasmatic nucleus. Neuroscience 1999, 89:387-397.
218. Shen T., Horwitz K.B., Lange C.A. Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294. Molecular and Cellular Biology 2001, 21:6122-6131.
219. Sherwin B.B. Progestogens used in menopause. Side effects, mood and quality of life. Journal of Reproductive Medicine 1999, 44:227-232.
220. Shiau A.K., Barstad D., Loria P.M., Cheng L., Kushner P.J., Agard D.A., Greene G.L. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 1998, 95:927937.
221. Shyamala G., Yang X., CardiffR.D., Dale E. Impact of progesterone receptor on cell-fate decisions during mammary gland development. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:3044-3049.
222. Shyamala G., Yang X., Silberstein G., Barcellos-HoffM.H., Dale E. Transgenic mice carrying an imbalance in the native ratio of A to B forms of progesterone receptor exhibit developmental abnormalities in mammary glands. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:696-701.
223. Sicinski P., Donaher J.L., Parker S.B., et al. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 1995, 82:621-630.
224. Simerly R.B., Seil F.J. Distribution and regulation of steroid hormone receptor gene expression in the central nervous system. Advances in Neurology 1993, 207. Raven Press, New York. F.J. Seil (Ed.).
225. Skildum A., Faivre E., Lange C.A. Progesterone receptors induce cell cycle progression via activation of mitogen-activated protein kinases. Molecular Endocrinology 2005, 19:327-339.
226. Smith C.L., Oñate S.A., Tsai M.J., O'Malley B.W. CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:8884-8888.
227. Sodersten P. Effects of anti-oestrogen treatment of neonatal male rats on lordosis behaviour and mounting behaviour in the adult. Journal of Endocrinology 1978, 76:241-249.
228. Sodersten P., Hansen S. Effects of oestradiol and progesterone on the induction and duration of sexual receptivity in cyclic female rats. Journal of Endocrinology 1977, 74:477485.
229. Spencer T.E., Jenster G., Burcin M.M., et al. Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 1997, 389:194-197.
230. Stromberg H., Svensson S.P., Hermanson O. Distribution of CREB-binding protein immunoreactivity in the adult rat brain. Brain Research 1999, 818:510-514.
231. Suen C.S., Berrodin T.J., Mastroeni R., Cheskis B.J., Lyttle C.R., Frail D.E. A transcriptional coactivator, steroid receptor coactivator-3, selectively augments steroid receptor transcriptional activity. Journal of Biological Chemistry 1998, 273:27645-27653.
232. Takimoto G.S., Horwitz K.B. Progesterone receptor phosphorylation - complexities in defining a functional role. Trends in Endocrinology and Metabolism 1993, 4:1-7.
233. Takimoto G.S., Hovland A.R., Tasset D.M., Melville M.Y., Tung L., Horwitz K.B. Role of phosphorylation on DNA binding and transcriptional functions of human progesterone receptors. Journal of Biological Chemistry 1996, 271:13308-13316.
234. Takimoto G.S., Tasset D.M., Eppert A.C., Horwitz K.B. Hormone-induced progesterone receptor phosphorylation consists of sequential DNA-independent and DNA-dependent stages: Analysis with zinc finger mutants and the progesterone antagonist ZK98299. Proceedings of the National Academy of Sciences of the United States of America 1992, 89:3050-3054.
235. Tanenbaum D.M., Wang Y., Williams S.P., Sigler P.B. Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:5998-6003.
236. Tennent B.J., Smith E.R., Davidson J.M. The effects of estrogen and progesterone on female rat proceptive behavior. Hormones and Behavior 1980, 14:65-75.
237. Tetel M.J., Giangrande P.H., Leonhardt S.A., McDonnell D.P., Edwards D.P. Hormone-dependent interaction between the amino- and carboxyl-terminal domains of progesterone receptor in vitro and in vivo. Molecular Endocrinology 1999, 13:910-924.
238. Tetel M.J., Jung S., Carbajo P., Ladtkow T., Skafar D.F., Edwards D.P. Hinge and amino-terminal sequences contribute to solution dimerization of human progesterone receptor. Molecular Endocrinology 1997, 11:1114-1128.
239. Tetel M.J., Siegal N.K., Murphy S.D. Cells in behaviourally relevant brain regions coexpress nuclear receptor coactivators and ovarian steroid receptors. Journal of Neuroendocrinology 2007, 19:262-271.
240. Tetel M.J., Ungar T.C., Hassan B., Bittman E.L. Photoperiodic regulation of androgen receptor and steroid receptor coactivator-1 in Siberian hamster brain. Molecular Brain Research 2004, 131:79-87.
241. Tora L., White J., Brou C., Tasset D., Webster N., Scheer E., Chambon P. The human estrogen receptor has two independent non-acidic transcriptional activation functions. Cell 1989, 59:477-487.
242. Torchia J., Rose D.W., Inostroza J., Kamei Y., Westin S., Glass C.K., Rosenfeld M.G. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 1997, 387:677-684.
243. Tsai M.J., O'Malley B.W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annual Review of Biochemistry 1994, 63:451-486.
244. Tseng L., Tang M., Wang Z., Mazella J. Progesterone receptor (hPR) upregulates the fibronectin promoter activity in human decidual fibroblasts. DNA Cell Biology 2003, 22:633-640.
245. Tung L., Abdel-Hafiz H., Shen T., et al. Progesterone receptors (PR)-B and -A regulate transcription by different mechanisms: AF-3 exerts regulatory control over coactivator binding to PR-B. Molecular Endocrinology 2006, 20:2656-2670.
246. Tung L., Kamel Mohamed M., Hoeffler J.P., Takimoto G.S., Horwitz K.B. Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors. Molecular Endocrinology 1993, 7:1256-1265.
247. Unni E., Sun S., Nan B., McPhaul M.J., Cheskis B., Mancini M.A., Marcelli M. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence. Cancer Research 2004, 64:7156-7168.
248. van Der Laan S., Lachize S.B., Schouten T.G., Vreugdenhil E., DeKloet E.R., Meijer O.C. Neuroanatomical distribution and colocalisation of nuclear receptor corepressor (N-CoR) and silencing mediator of retinoid and thyroid receptors (SMRT) in rat brain. Brain Research 2005, 1059:113-121.
249. van Der Laan S., Lachize S.B., Vreugdenhil E., DeKloet E.R., Meijer O.C. Nuclear receptor coregulators differentially modulate induction and glucocorticoid receptor-mediated repression of the corticotropin-releasing hormone gene. Endocrinology 2008, 149:725-732.
250. van Der Schoot P. Effects of dihydrotestosterone and oestradiol on sexual differentiation in male rats. Journal of Endocrinology 1980, 84:397-407.
251. Vasudevan N., Zhu Y.S., Daniel S., Koibuchi N., Chin W.W., PfaffD. Crosstalk between oestrogen receptors and thyroid hormone receptor isoforms results in differential regulation of the preproenkephalin gene. Journal of Neuroendocrinology 2001, 13:779-790.
252. Vegeto E., Shahbaz M.M., Wen D.X., Goldman M.E., O'Malley B.W., McDonnell D.P. Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. Molecular Endocrinology 1993, 7:1244-1255.
253. Vicent G.P., Ballare C., Zaurin R., Saragueta P., Beato M. Chromatin remodeling and control of cell proliferation by progestins via cross talk of progesterone receptor with the estrogen receptors and kinase signaling pathways. Annals of the New York Academy Sciences 2006, 1089:59-72.
254. Vo N., Goodman R.H. CREB-binding protein and p300 in transcriptional regulation. Journal of Biological Chemistry 2001, 276:13505-13508.
255. Voegel J.J., Heine M.J.S., Zechel C., Chambon P., Gronemeyer H. TIF2, a 160kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO Journal 1996, 15:3667-3675.
256. Wagner C.K. The many faces of progesterone: A role in adult and developing male brain. Frontiers in Neuroendocrinology 2006, 27:340-359.
257. Wagner C.K. Progesterone receptors and neural development: A gap between bench and bedside?. Endocrinology 2008, 149:2743-2749.
258. Wang Z., Qi C., Krones A., et al. Critical roles of the p160 transcriptional coactivators p/CIP and SRC-1 in energy balance. Cell Metabolism 2006, 3:111-122.
259. Ward I.L., Renz F.J. Consequences of perinatal hormone manipulation on the adult sexual behavior of female rats. Journal of Comparative and Physiological Psychology 1972, 78:349-355.
260. Wardell S.E., Boonyaratanakornkit V., Adelman J., Aronheim A., Edwards D.P. Jun dimerization protein 2 functions as a progesterone receptor N-terminal domain coactivator. Molecular and Cellular Biology 2002, 22:5451-5466.
261. Warembourg M., Jolivet A., Milgrom E. Immunohistochemical evidence of the presence of estrogen and progesterone receptors in the same neurons of the guinea pig hypothalamus and preoptic area. Brain Research 1989, 480:1-15.
262. Webb P., Nguyen P., Shinsako J., et al. Estrogen receptor activation function 1 works by binding p160 coactivator proteins. Molecular Endocrinology 1998, 12:1605-1618.
263. Weigel N.L., Moore N.L. Steroid receptor phosphorylation: A key modulator of multiple receptor functions. Molecular Endocrinology 2007, 21:2311-2319.
264. Weiss R.E., Xu J., Ning G., Pohlenz J., O'Malley B.W., RefetoffS. Mice deficient in the steroid receptor co-activator 1 (SRC-1) are resistant to thyroid hormone. EMBO Journal 1999, 18:1900-1904.
265. Wen D.X., Xu Y.F., Mais D.E., Goldman M.E., McDonnell D.P. The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells. Molecular and Cellular Biology 1994, 14:8356-8364.
266. Whalen R.E. Estrogen-progesterone induction of mating in female rats. Hormones and Behavior 1974, 5:157-162.
267. Whalen R.E., Edwards D.A. Hormonal determinants of the development of masculine and feminine behavior in male and female rats. Anatomical Records 1967, 157:173-180.
268. Wong C.W., McNally C., Nickbarg E., Komm B.S., Cheskis B.J. Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:14783-14788.
269. Wu R.C., Qin J., Yi P., Wong J., Tsai S.Y., Tsai M.J., O'Malley B.W. Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic reponses to multiple cellular signaling pathways. Molecular Cell 2004, 15:937-949.
270. Wu R.C., Smith C.L., O'Malley B.W. Transcriptional regulation by steroid receptor coactivator phosphorylation. Endocrine Reviews 2005, 26:393-399.
271. Xu J., Liao L., Ning G., Yoshida-Kimoya H., Deng C., O'Malley B.W. The steroid receptor coactivator SRC-3 (p/cip/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:6379-6384.
272. Xu J., Qiu Y., Demayo F.J., Tsai S.Y., Tsai M.J., O'Malley B.W. Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. Science 1998, 279:1922-1925.
273. Xu Y., Klein-Hitpass L., Bagchi M.K. E1A-mediated repression of progesterone receptor-dependent transactivation involves inhibition of the assembly of a multisubunit coactivation complex. Molecular and Cellular Biology 2000, 20:2138-2146.
274. Yang X.J., Ogryzko V.V., Nishikawa J., Howard B.H., Nakatani Y. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 1996, 382:319-324.
275. Zhang Y., Beck C.A., Poletti A., Edwards D.P., Weigel N.L. Identification of phosphorylation sites unique to the B form of human progesterone receptor In vitro phosphorylation by casein kinase II. Journal of Biological Chemistry 1994, 269:31034-31040.
276. Zhang Y., Beck C.A., Poletti A., Edwards D.P., Weigel N.L. Identification of a group of Ser-Pro motif hormone-inducible phosphorylation sites in the human progesterone receptor. Molecular Endocrinology 1995, 9:1029-1040.
277. Zhang Y., Beck C.A., Poletti A., et al. Phosphorylation of human progesterone receptor by cyclin-dependent kinase 2 on three sites that are authentic basal phosphorylation sites in vivo. Molecular Endocrinology 1997, 11:823-832.
278. Zhoul J., Hernandez G., Tu S.W., Huang C.L., Tseng C.P., Hsieh J.T. The role of DOC-2/DAB2 in modulating androgen receptor-mediated cell growth via the nongenomic c-Src-mediated pathway in normal prostatic epithelium and cancer. Cancer Research 2005, 65:9906-9913.
279. Zhu Y., Bond J., Thomas P. Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:2237-2242.